KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Retained Earnings (2018 - 2025)

ClearPoint Neuro's Retained Earnings history spans 13 years, with the latest figure at -$209.1 million for Q3 2025.

  • For Q3 2025, Retained Earnings changed N/A year-over-year to -$209.1 million; the TTM value through Sep 2025 reached -$209.1 million, changed N/A, while the annual FY2024 figure was -$191.4 million, 10.97% down from the prior year.
  • Retained Earnings for Q3 2025 was -$209.1 million at ClearPoint Neuro, down from -$203.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$122.1 million in Q1 2021 and bottomed at -$209.1 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$156.0 million (2023), against an average of -$161.1 million.
  • The largest annual shift saw Retained Earnings decreased 6.33% in 2021 before it dropped 14.69% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$133.9 million in 2021, then dropped by 12.27% to -$150.4 million in 2022, then fell by 14.69% to -$172.5 million in 2023, then fell by 10.97% to -$191.4 million in 2024, then decreased by 9.28% to -$209.1 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Retained Earnings are -$209.1 million (Q3 2025), -$203.2 million (Q2 2025), and -$197.4 million (Q1 2025).